THE USE OF OMEGA-3 FATTY ACIDS FOR THE TREATMENT OF PATIENTS WITH CARDIAC ARRHYTHMIAS

THE USE OF OMEGA-3 FATTY ACIDS FOR THE TREATMENT OF PATIENTS WITH CARDIAC ARRHYTHMIAS

Show other versions (1)

<p>Antiarrhythmic effect of omega-3 polyunsaturated fatty acids (ω-3 PUFA), eicosapentaenoic and docosahexaenoic acids in patients with recurrent atrial fibrillation and ventricular arrhythmias had been proven. The positive effect of the ω-3 PUFA on the risk of sudden arrhythmic death and over...

Full description

Bibliographic Details
Main Authors:	A. O. Malygin, V. L. Doshchitsin
Format:	Article
Language:	English
Published:	Stolichnaya Izdatelskaya Kompaniya 2015-09-01
Series:	Racionalʹnaâ Farmakoterapiâ v Kardiologii
Subjects:	омега-3 полиненасыщенные жирные кислоты аритмии фибрилляция предсердий атеросклероз
Online Access:	http://www.rpcardio.ru/jour/article/view/44

Similar Items

ИССЛЕДОВАНИЕ АНТИАРИТМИЧЕСКИХ ЭФФЕКТОВ ОМЕГА-3 ПОЛИНЕНАСЫЩЕННЫХ ЖИРНЫХ КИСЛОТ В КАРДИОХИРУРГИИ. ДАННЫЕ ИМПЛАНТИРУЕМОГО МОНИТОРА РИТМА СЕРДЦА
by: С. М. Ефремов, et al.
Published: (2015-10-01)

Blubber fatty acids of marine and freshwater seals.
by: E. S. Averina, et al.
Published: (2009-06-01)

Vliyanie ω-3-polinenasyshchennykh zhirnykh kislot na svobodnoradikal'nye protsessy i strukturnoe sostoyanie membran eritrotsitov u patsientov s metabolicheskim sindromom
Published: (2010-09-01)

THE "NEW" DRUG CLASSES IN THE TREATMENT OF CHRONIC HEART FAILURE AND THEIR EVIDENCE BASE
by: S. N. Tereshchenko, et al.
Published: (2015-12-01)

Lipoxygenation of fatty acids in plants
by: A. B. Golovanov, et al.
Published: (2008-12-01)

Options of dyslipidemia treatment at non-alcoholic fatty liver disease
by: M. V. Mayevskaya, et al.
Published: (2018-08-01)

OMEGA-3 POLYUNSATURATED FATTY ACIDS IN THE TREATMENT OF PATIENTS WITH CARDIOVASCULAR DISEASES
by: A. V. Govorin, et al.
Published: (2015-12-01)

Predposylki k primeneniyu omega-3 polinenasyshchennykh zhirnykh kislot u zhenshchin v klimaktericheskom periode
by: S P Sinchikhin, et al.
Published: (2009-10-01)

STUDYING FORMATION THE SMELL OF FISH CHOPPED SEMIS AT ENRICHMENT THEM BY POLYUNSATURATED FATTY ACIDS USING A PIEZO SORPTION "ELECTRONIC NOSE"
by: N. N. Popova, et al.
Published: (2013-07-01)

Study of the composition and content of fatty acids in herbal remedies
by: T A Lobaeva
Published: (2015-12-01)

Therapeutic role of polyunsaturated fatty acids and of their derivatives in pathophysiological processes
by: N. V. Groza, et al.
Published: (2012-10-01)

Substrate Modification in Catheter Treatment of Atrial Fibrillation
by: Oleksandr S. Stychynskyi, et al.
Published: (2021-09-01)

CHANGE OF LOCAL MYOCARDIAL CONTRACTILITY DUE TO SELECTION OF DIFFERENT ARRHYTHMIA TREATMENT STRATEGIES IN PATIENTS WITH ISCHEMIC HEART DISEASE AND PAROXYSMAL ATRIAL FIBRILLATION
by: V. I. Podzolkov, et al.
Published: (2015-09-01)

UP TO DAY POSSIBILITIES OF ATRIAL FIBRILLATION PREVENTION
by: E. A. Protasova, et al.
Published: (2015-12-01)

ПАТОГЕНЕЗ, ПРОФИЛАКТИКА И ЛЕЧЕНИЕ ФИБРИЛЛЯЦИИ ПРЕДСЕРДИЙ ПОСЛЕ КАРДИОХИРУРГИЧЕСКИХ ВМЕШАТЕЛЬСТВ
by: статья Редакционная
Published: (2015-10-01)

Влияние высокожировых рационов с различным жирнокислотным составом на содержание незаменимых жирных кислот в липидах печени = Influence of high fat diets with different composition of fatty acids on the content of essential fatty acids in liver lipids
by: A. P. Levitsky, et al.
Published: (2015-12-01)

COMPARATIVE CHARACTERISTICS OF THE LIPID STATUS OF ATLANTIC SALMON SALMO SALAR L. jUVENILES OF DIFFERENT AGES FROM THE VARZUGA RIVER (KOLA PENINSULA)
by: Svetlana Pekkoeva, et al.
Published: (2018-04-01)

THE EFFICACY OF COMBINED BIOMARKER TESTS IN EARLY DIAGNOSTICS OF ACUTE MYOCARDIAL INFARCTION AFTER CLINICAL SYMPTOMS ONSET: ROLE OF HEART-TYPE FATTY ACID-BINDING PROTEIN
by: O. V. Baturina, et al.
Published: (2015-12-01)

MODERN APPROACHES TO ANTICOAGULANT THERAPY DURING CATHETER ABLATION TREATMENT OF NON-VALVULAR ATRIAL FIBRILLATION
by: E. A. Belikov, et al.
Published: (2015-09-01)

PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN ATRIAL FIBRILLATION - RAT POISON OR NEW ORAL ANTICOAGULANTS: DO WE HAVE A CHOICE, AND SHOULD WE BE AFRAID TO MAKE IT? FIRST CLINICAL EXPERIENCE WITH RIVAROXABAN IN NIZHNY NOVGOROD
by: L. Y. Koroleva, et al.
Published: (2015-09-01)

Clinical significance of TNF-a assessment as inflammation marker in paroxysmal atrial fibrillation
by: E M Esedov, et al.
Published: (2014-12-01)

Functional activity of intestinal microbiota with metabolic syndrome
by: Al'bert A. Kurmangulov, et al.
Published: (2015-09-01)

CLINICAL IMPLICATION OF FATTY ACID CHANGES IN PATIENTS WITH PRIMARY GOUT ASSOCIATED WITH ARTERIAL HYPERTENSION
by: N. N. Kushnarenko, et al.
Published: (2015-12-01)

CARDIAC INSUFFICIENCY FREQUENCY AND ANTI-THROMBOTIC THERAPY IN PATIENTS WITH ATRIAL FIBRILLATION ACCORDING TO THE INFORMATION PROVIDED BY THE HOSPITAL REGISTR KRAF
by: Nikolai Gamletovich Gogolashvili, et al.
Published: (2019-07-01)

ATRIAL FIBROSIS IS A MORPHOLOGICAL BASIS OF ATRIAL FIBRILLATION
by: O. M. Drapkina, et al.
Published: (2015-09-01)

THE USE OF OMEGA-3 FATTY ACIDS FOR THE TREATMENT OF PATIENTS WITH CARDIAC ARRHYTHMIAS
by: A. O. Malygin, et al.
Published: (2015-09-01)

Длительное применение апиксабана у 91-летней пациентки с фибрилляцией предсердий, имеющей высокие риски тромбоэмболических и геморрагических осложнений
Published: (2016-12-01)

Catheter versus surgical ablation of atrial fibrillation after failed initial pulmonary vein isolation
by: Д. А. Елесин, et al.
Published: (2015-10-01)

RIVAROXABAN IN THE PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN PATIENTS WITH ATRIAL FIBRILLATION
by: M. Yu. Gilyarov
Published: (2015-12-01)

THE RISK OF BLEEDINGS IN PATIENTS WITH ATRIAL FIBRILLATION DURING ANTICOAGULANT THERAPY
by: M. Yu. Gilyarov
Published: (2015-12-01)

STROKE AS A RISK FACTOR IN PATIENTS WITH ATRIAL FIBRILLATION ACCORDING TO THE KRAF HOSPITAL REGISTER
by: Alexander Aleksandrovich Tuchkov, et al.
Published: (2019-07-01)

МЕТОД ОЦЕНКИ СОЦИАЛЬНОЙ КОМПЛАЕНТНОСТИ КАК ФОРМЫ СОЦИАЛЬНОЙ ОТВЕТСТВЕННОСТИ ПАЦИЕНТА
by: S. L. Boiko, et al.
Published: (2021-05-01)

Modulation of sympathetic nervous system by means of renal denervation for treatment of atrial fibrillation
by: А. Б. Романов, et al.
Published: (2015-10-01)

Comparison of biatrial and left atrial radiofrequency ablation in patients with heart valves diseases
by: А. В. Богачев-прокофьев, et al.
Published: (2015-10-01)

Adherence to drug therapy in patients with atrial fibrillation
by: М A Kachkovskiy, et al.
Published: (2010-12-01)

ROLE OF HYPERTENSION AND SUPRAVENTRICULAR ARRHYTHMIAS IN COGNITIVE IMPAIRMENTS: THE CURRENT PROBLEM STATE
by: N. N. Kriukov, et al.
Published: (2015-09-01)

SECONDARY PREVENTION OF STROKE IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION: THE CLINICIANS’ VIEWPOINT
by: E. A. Drozdova
Published: (2015-09-01)

CHRONIC KIDNEY DISEASE AND CARDIOVASCULAR DISEASES: FOCUS ON ATRIAL FIBRILLATION
by: V. N. Shishkova
Published: (2015-09-01)

ATRIAL FIBRILLATION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: E. I. Leonova, et al.
Published: (2015-09-01)

AN OUTPATIENT WITH ATRIAL FIBRILLATION: KEY FEATURES. THE FIRST DATA OF REKVAZA FP - YAROSLAVL REGISTER
by: V. V. Yakusevich, et al.
Published: (2015-09-01)